Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
Eterna Therapeutics (ERNA) Stock Price & Analysis
213 Followers
ERNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.90 - $15.60
Previous Close$2.17
Volume33.48K
Average Volume (3M)22.55K
Market Cap
$11.44M
Enterprise Value$7.05M
Total Cash (Recent Filing)$5.40M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)-0.4
Beta1.52
Next Earnings
Apr 14, 2023EPS Estimate
-$2.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.72
Shares Outstanding5,270,072
10 Day Avg. Volume99,590
30 Day Avg. Volume22,554
Standard Deviation1.63
R-Squared0.02
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue111.87
Enterprise Value/Gross Profit83.91
Enterprise Value/Ebitda-0.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eterna Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ERNA FAQ
What was Eterna Therapeutics’s price range in the past 12 months?
Eterna Therapeutics lowest stock price was $1.90 and its highest was $15.60 in the past 12 months.
What is Eterna Therapeutics’s market cap?
Currently, no data Available
When is Eterna Therapeutics’s upcoming earnings report date?
Eterna Therapeutics’s upcoming earnings report date is Apr 14, 2023 which is 49 days ago.
How were Eterna Therapeutics’s earnings last quarter?
Eterna Therapeutics released its earnings results on Nov 08, 2022. The company reported -$2.488 earnings per share for the quarter, missing the consensus estimate of -$2.2 by -$0.288.
Is Eterna Therapeutics overvalued?
According to Wall Street analysts Eterna Therapeutics’s price is currently Overvalued.
Does Eterna Therapeutics pay dividends?
Eterna Therapeutics does not currently pay dividends.
What is Eterna Therapeutics’s EPS estimate?
Eterna Therapeutics’s EPS estimate is -$2.4.
How many shares outstanding does Eterna Therapeutics have?
Eterna Therapeutics has 5,270,072 shares outstanding.
What happened to Eterna Therapeutics’s price movement after its last earnings report?
Eterna Therapeutics reported an EPS of -$2.488 in its last earnings report, missing expectations of -$2.2. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Eterna Therapeutics?
Currently, no hedge funds are holding shares in ERNA
---
Eterna Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.33%
12-Months-Change
Fundamentals
Return on Equity
-167.02%
Trailing 12-Months
Asset Growth
-57.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Eterna Therapeutics
NTN Buzztime, Inc. engages in the provision of entertainment and innovative technology services. It offers entertainment, live events, dining, marketing, hardware, and pricing products. It also includes performance analytics and secure payment with Europay, MasterCard, and Visa chip readers or with near-field communication (NFC) technology to accept Apple, Android, and Samsung Pay. The company was founded in 1984 and is headquartered in Carlsbad, CA.
---
Top 5 ETFs holding ERNA
iShares Core S&P Total U.S. Stock Market ETF
$2.00K
Up to five ETFs with an Outperform Smart Score that hold ERNA. The ETFs are listed according to market value of ERNA within the ETF
---
---